Icomix (Helium, Carbon Monoxide)

Icomix is used in respiratory therapy and diagnostic procedures involving the pulmonary system.

• Pulmonary function testing: Helium‑oxygen mixture improves measurement accuracy by reducing airway turbulence.
• Ventilation‑perfusion scanning: Carbon monoxide component serves as a radiotracer to assess regional lung perfusion.
• Airway obstruction management: Heliox can decrease airway resistance and improve ventilation in patients with obstructive airway disease.

• Helium, due to its low density, reduces airway resistance and turbulence, facilitating airflow during inhalation. Carbon monoxide binds to hemoglobin with high affinity, forming carboxyhemoglobin; in controlled low concentrations it is used as a radiotracer for perfusion imaging and can modulate vascular tone. Together, the gases provide diagnostic contrast and therapeutic airflow benefits when administered under strict clinical supervision.

Adverse reactions may occur with inhalation of medical gases and should be monitored.

Common Side Effects

• Cough or throat irritation
• Dizziness or light‑headedness
• Headache
• Nausea
• Mild hypoxia
• Transient increase in heart rate

Serious or Rare Side Effects

• Carbon monoxide poisoning leading to severe hypoxemia
• Loss of consciousness
• Arrhythmias
• Pulmonary edema
• Methemoglobinemia
• Severe respiratory depression

Careful assessment and monitoring are required when using Icomix.

• Assess respiratory status: evaluate baseline lung function before administration.
• Monitor oxygen saturation: continuous pulse‑oximetry during inhalation.
• Avoid use in severe anemia: reduced hemoglobin limits oxygen transport.
• Limit exposure duration: follow institutional protocols for gas delivery time.
• Use only under qualified supervision: trained personnel must administer and supervise.
• Store at ambient temperature: keep cylinders upright, protect from heat and direct sunlight.

Icomix may interact with other agents affecting gas exchange or hemoglobin binding.

Major Interactions (Avoid)

• Concurrent high‑concentration oxygen therapy: may alter gas mixture efficacy.
• Use with nitrous oxide anesthesia: increased risk of hypoxia.
• Co‑administration with agents that raise carboxyhemoglobin (e.g., sodium nitrite).

Moderate Interactions (Monitor Closely)

• Anticoagulants: potential additive bleeding risk with carbon monoxide exposure.
• Bronchodilators: possible additive airway effects.
• Sedatives or opioids: enhanced respiratory depression may occur.